Universal Corporation Q1 FY2027 earnings call

• Tobacco Business Operations and Strategy

  • The company is executing disciplined buying strategies amid a global oversupply of most tobacco types, leveraging its diverse global footprint, agronomy/logistics expertise, sustainability practices, and financial stability to maintain and gain market share
  • For dark air-cured tobacco: wrapper demand remains strong, while non-wrapper dark tobacco continues to face oversupply. New sales and inventory management initiatives have been implemented to optimize margins: enhanced customer communication to align purchasing and sales plans, a targeted purchasing strategy that prioritizes high-demand wrapper tobacco and minimizes low-demand non-wrapper volumes, and a goal of reducing overall inventory levels by converting existing stock to cash
  • Worldwide uncommitted flue-cured and burley tobacco leaf totaled approximately 180 million kilos at June 30, up 11 million kilos from March 31

• Universal Ingredients Business Operations and Commitment

  • Management remains fully committed to Universal Ingredients as a long-term growth engine for the company, after 6 years of investment in capacity and capabilities at the Lancaster campus
  • Current priorities are to improve facility utilization, increase volume of value-added solutions-based products, drive operational and cost efficiencies to expand margins, and implement commercial execution initiatives to support growth
  • A recent leadership change was made to bring in a new growth-focused leader to advance the segment from its current early growth stage to its next phase of expansion

• Capital Allocation Priorities

  • Stated priorities in order: investment in core tobacco operations, support for the regular dividend, investment for growth in the ingredients segment, and returning excess capital to shareholders via share repurchases
  • Fiscal 2027 capital expenditure is budgeted at 55-65 million yen, focused on growth investments, facility efficiency improvements, and automation across multiple tobacco-producing regions, following prior growth investment in the ingredients segment
  • The recent quarter's share repurchase activity was completed primarily to offset dilution from equity compensation programs, a return to the company's historical practice of maintaining diluted shares outstanding around 25 million

The provided Q&A-focused transcript does not include full absolute financial results or revenue contribution percentages for Universal's two core segments (Tobacco and Universal Ingredients). For the tobacco segment, the call notes that Q1 tobacco margins were at a seasonally low level driven by product mix and sales of carryover crops. For the Universal Ingredients segment, the call mentions ongoing fixed cost pressure at the expanded Lancaster campus due to low capacity utilization amid weak customer volumes from broader macroeconomic challenges.

• Full-year fiscal 2027 tobacco sales are expected to meet the company's existing plan, with early-season execution and customer commitments aligned with targets. Tobacco margins are expected to return to normalized historical percentage levels in the second half of the fiscal year, with no expected further deterioration
• Uncommitted tobacco inventory levels are expected to decline through the season and reach the company's 20% target by year end, as sales pace has already picked up from the start of the fiscal year
• Full-year working capital is expected to decrease compared to recent years, driven by lower green tobacco purchasing prices; quarter-to-quarter fluctuations will depend on the pace of sales and shipment timing
• Full-year SG&A is expected to remain in the historical range of 300-310 million yen. Interest expense is expected to decrease slightly year-over-year due to slower purchasing pace and lower working capital from reduced green tobacco prices
• The company expects to see benefits from the new dark air-cured tobacco inventory and sales initiatives during fiscal 2027, with no large additional inventory write-downs expected after the fourth quarter of fiscal 2026

• Persistent global oversupply of non-wrapper dark air-cured tobacco and most other tobacco types creates pressure on pricing, margins, and inventory levels
• El Niño weather patterns create uncertainty around growing conditions and crop availability for next season's tobacco harvest, with unclear near-term impacts on production and supply
• Universal Ingredients' expanded Lancaster campus has low capacity utilization, leading to fixed cost absorption challenges amid weak customer demand from broader macroeconomic headwinds

Q: Daniel Harriman (Sudoti) asked what visibility the company has into the back half of the fiscal year that supports confidence in hitting full-year tobacco sales plans, and whether there is additional write-down risk for dark air-cured tobacco in fiscal 2027. / A: Management stated that early season tobacco procurement has proceeded as planned, with disciplined buying, strong customer communication, and customer demand aligned with the full-year sales plan. The company's diverse global footprint lets it offset supply issues from any single origin, and lower farmer pricing is in line with expectations for an oversupplied market. For dark air-cured tobacco, wrapper demand remains strong while non-wrapper is still oversupplied; new sales and inventory initiatives have been implemented to prioritize high-demand stock and reduce overall inventory, and management does not expect the large write-downs seen in the prior year. (512 characters)

Q: Anne Gerken (Davenport) asked what tobacco margin expectations are for the second half of fiscal 2027, and how uncommitted inventory levels will progress through the year. / A: Management noted that Q1's low tobacco margin was driven by seasonality, product mix, and carryover crop sales, and expects margins to return to normalized historical levels for the rest of the year. While uncommitted inventory was elevated early in the season in slower markets like parts of South America and Africa, sales pace has picked up in recent months, and uncommitted levels have already fallen from the June 30 level. Management expects uncommitted inventory to reach the 20% target by year end. (478 characters)

Q: Gerken asked about the company's capital allocation priorities and the rationale for recent share repurchases amid lower near-term earnings. / A: Management explained that the recent share repurchase was only to offset dilution from equity compensation, returning to the company's historical practice of maintaining ~25 million diluted shares outstanding. Capital allocation priorities, in order, are: investing in tobacco operations, maintaining and growing the dividend, expanding the ingredients segment, and returning additional capital via share repurchases. 2027 capex of 55-65 million is focused on efficiency and growth projects for tobacco across multiple regions after prior investment in ingredients. (421 characters)

Q: Gerken asked about management's long-term commitment to the ingredients segment, the expected pace of margin and volume recovery, and current capacity utilization at the Lancaster campus. / A: Management reaffirmed full long-term commitment to ingredients as a core growth engine, noting that the recent leadership change was to bring in a growth-focused leader to scale the segment after its initial 6 years of development. Current initiatives are focused on increasing capacity utilization at the expanded Lancaster campus, growing volume of profitable value-added products, and driving cost efficiencies, with steady incremental growth expected over time. Management declined to share a specific current capacity utilization number, only confirming it is lower than targeted. (483 characters)